Author:
Burgers Jessica,Azizi Armina,Singh Vedant
Abstract
Abstract
Purpose of Review
With the aging population of the USA, the role of mammographic screening over the age of 75 is controversial. This review investigates the benefits, risks, and utilization of mammography screening in the geriatric population.
Recent Findings
The utilization of screening mammography in geriatric patients is variable and often not targeted to those who will receive the most benefit. Prognostic tools can help stratify those who will benefit from early detection versus those who will suffer harm from false positives and overdiagnosis. Decision aids are well received by both patient and physician and facilitate shared decision-making discussions.
Summary
Future research needs to include more patients over 70 years of age to provide stronger data on the benefits and risks. The dissemination of decision-making tools can help with messaging, and further research on the implementation and reception of these tools can help with their refinement.
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15–23. https://doi.org/10.1016/j.breast.2022.08.010.
2. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–41. https://doi.org/10.3322/caac.21754.
3. Wince-Smith D. Bracing for the silver tsunami [Internet]. Forbes Inc. 2022. https://www.forbes.com/sites/deborahwince-smith/2022/02/25/bracing-for-the-silver-tsunami/?sh=62becfd533e4.
4. Shrank WH, Rogstad TL, Parekh N. Waste in the US health care system: estimated costs and potential for savings. JAMA. 2019;322(15):1501–9. https://doi.org/10.1001/jama.2019.13978.
5. US Preventive Services Task Force breast cancer screening. https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults (2023).